Outcomes of Sleeve Gastrectomy in Obese Patients, Retrospective Study.
1 other identifier
observational
60
1 country
1
Brief Summary
This study will be a retrospective study in which we will review patients who underwent laparoscopic sleeve gastrectomy at Sohag University Hospital in the period from january 2017 to May 2018.Assessment of outcomes as Effects on weight, Effects on co-morbidities and Post operative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 13, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2022
CompletedJune 1, 2022
May 1, 2022
11 months
July 13, 2021
May 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects on weight reported as percentage of excess weight loss
It is calculated as (initial weight - follow-up weight)/(initial weight - ideal weight corresponding to BMI 25) × 100%.
minimum 2-year follow-up
Interventions
Laparoscopic sleeve gastrectomy gives long-standing improvement or resolution of obesity-related conditions and also survival benefit. It is highly cost-effective. Surgical procedures for the treatment of obesity.
Eligibility Criteria
both males and females, age from 18 to 65 yrs complain of obesity with body mass index ≥ 40 kg/m2 or body mass index ≥ 35 kg/m2 with comorbidities diseases.
You may qualify if:
- age from 18 to 65 years old
- body mass index ≥ 35 kg/m2 with comorbidities disease or body mass index ≥ 40 kg/m2, with failure of non operative attempts to lose weight
- a minimum 2-year follow-up at our outpatient clinic.
You may not qualify if:
- secondary causes of obesity (e.g. endocrine diseases)
- patients unable to participate in medical follow-up;
- associated comorbidities or diseases impacting on weight loss.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, 82524, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
July 13, 2021
First Posted
July 19, 2021
Study Start
July 1, 2021
Primary Completion
May 20, 2022
Study Completion
May 20, 2022
Last Updated
June 1, 2022
Record last verified: 2022-05